Trial Profile
A phase II study of Capecitabine in combination with oral vinorelbine in advanced Breast Cancer.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 31 May 2011
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Vinorelbine (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 31 May 2011 New trial record